(a) (1) No later than 30 days after the first marketing of a dietary supplement that bears one of the statements listed in section 403(r)(6) or the Federal Food, Drug, and Cosmetic Act, the manufacturer, packer, or distributor of the dietary supplement shall notify the Office of Dietary Supplement Programs (HFS-810), Center for Food Safety and Applied Nutrition, Food and Drug Administration, 5001 Campus Dr., College Park, MD 20740, that it has included such a statement on the label or in the labeling of its product
Objective of the campaign The objective of the campaign is to protect the health and well-being of young people from the harmful effects of tobacco
Cost is a major factor in adoption of technology 3
The failure to articulate a clear methodology for APPH, grounded in market and behavioral realities, is part of a wider, long-standing problem: FDA has never set out, in detail or even in principle, how it believes the benefit-cost assessment implicit in APPH should be made, and this guidance does not address this deficit at all